Dr. David Austin leads the PROACT study aiming to prevent chemotherapy-related heart damage in breast cancer and lymphoma patients using the ACE inhibitor enalapril. The research focuses on the effectiveness of enalapril in mitigating anthracycline cardiotoxicity, crucial for reducing long-term impa

3 views • 19 slides

This comprehensive review delves into the correlation between cardiac health and psychiatric medications, focusing on the QT and QTc intervals, antidepressants, antipsychotics, and cardiotoxicity associated with certain medications. It also explores the impact of depression on heart disease, risk fa

1 views • 47 slides